Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology

British Journal of Cancer

Volumn 77, Issue 6, 1998, Pages 956-964

  Banks, R E ^a   Forbes, M A ^a   Kinsey, S E ^a   Stanley, A ^a   Ingham, E ^b   Walters, C ^b   Selby, P J ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Angiogenesis; Assay; Megakaryocytes; Platelets; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; VASCULOTROPIN;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; BONE MARROW; CANCER; CELL INTERACTION; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; EXTRAVASATION; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MALE; MEGAKARYOCYTE; METASTASIS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; TUMOR CELL; VEIN PUNCTURE; WOUND HEALING;

EID: 0031889548     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.158     Document Type: Article

References (70)

1. Abu-Jawdeh GM, Faix JD, Niloff J, Tognazzi K, Manseau E, Dvorak HF and Brown LF (1996) Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Lab Invest 74: 1105-1115
2. Anan K, Morisaki T, Katano M, Ikubo A, Kitsuki H, Uchiyama A, Kuroki S, Tanaka M and Torisu M (1996) Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Surgery 119: 333-339
3. [2]. Cancer Res 55: 5296-5301
4. Aye MT, Palmer DS, Giulivi A and Hashemi S (1995) Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion 35: 117-124
5. Baker PN, Krasnow J, Roberts JM and Yeo KT (1995) Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol 86: 815-821
6. Banks RE, Forbes MA, Stanley A, Kinsey S, Ingham E, Walters C and Selby PJ (1996) Presence of vascular endothelial growth factor (VEGF) in megakaryocytes and platelets (abstract). Br J Haematol 93: A78
7. Barleon B, Snzzani S, Zhou D, Weich HA, Mantovani A and Mamé D (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87: 3336-3343
8. Blood CH and Zetter BR (1990) Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1032: 89-118
9. Boocock CA, Charnock-Jones DS, Sharkey AM, McLaren J, Barker PJ, Wright KA, Twentyman PR and Smith SK (1995) Expression of vascular endothelial growth factor and its receptors fit and KDR in ovarian carcinoma. J Natl Cancer Inst 87: 506-516
10. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF and Senger DR (1993a) Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 143: 1255-1262
11. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR and Dvorak HF (1993b) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 53: 4727-4735
12. Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi AJ, Dvorak HF, Senger DR, Connolly JL and Schnitt SJ (1995) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 26: 86-91
13. Broxmeyer HE, Cooper S, Li ZH, Lu L, Song HY, Kwon BS, Warren RE and Donner DB (1995) Myeloid progenitor cell regulatory effects of vascular endothelial cell growth factor. Int J Haemutol 62: 203-215
14. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Lieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declerq C, Pawling J, Moons L, Collen D, Risau W and Nagy A (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439
15. Claffey KP, Brown LF, Del Aguila LF, Tognazzi K, Yeo KT, Manseau EJ and Dvorak HF (1996) Expression of vascular permeability factor vascular endothelial growth factor by melanoma cells increases tumor growth. angiogenesis, and experimental metastasis. Cancer Res 56: 172-181
16. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N and Williams LT (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989-991
17. Diaz-Flores L, Gutierrez R and Varela H (1994) Angiogenesis: an update. Histol Histopathol 9: 807-843
18. Dirix LY, Vermeulen PB, Pawinski A, Prove A, Benoy I, De Pooter C, Martin M and Van Oosterom (1997). Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br J Cancer 76: 238-243
19. Dvorak HF, Brown IF, Detmar M and Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039
20. Ferrara N, Heinsohn H, Walder CE, Bunting S and Thomas GR (1995) The regulation of blood vessel growth by vascular endothelial growth factor. Ann NY Acad Sci 752: 246-256
21. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ and Moore MW (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442
22. Ferrari G and Scagliotti GV (1996) Serum and urinary vascular endothelial growth factor levels in non-small cell lung cancer patients. Eur J. Cancer 32A: 2368-2369
23. Flegel WA, Wiesneth M, Stampe D and Koerner K (1995) Low cytokine contamination in buffy coat-derived platelet concentrates without filtration. Transfusion 35: 917-920
24. Folkman J (1995) Clinical applications of research on angiogenesis. New Engl J Med 333: 1757-1763
25. Folkman J and Shing Y (1992) Angiogenesis. J Biol Chem 267: 10931-10934
26. Freeman MR, Schneck FX, Gagnon ML, Corless C, Soker S, Niknejad K, Peoples GE and Klagsbrun M (1995) Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: A potential role for T cells in angiogenesis. Cancer Res 55: 4140-4145
27. Grimmond S, Lagercrantz J, Drinkwater C, Silins G, Townson S, Pollock P, Gotley D, Carson E, Rakar S, Nordenskjöld M, Ward L, Hayward N and Weber G (1996) Cloning and characterization of a novel human gene related to vascular endothelial growth factor. Genome Res 6: 124-131
28. Guidi AJ, Fischer L, Harris JR and Schnitt SJ (1994) Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst 86: 614-619
29. Hanatani M, Tanaka Y, Kondo S, Ohmori I and Suzuki H (1995) Sensitive chemiluminescence enzyme immunoassay for vascular endothelial growth factor vascular permeability factor in human serum. Biosci Biotechnol Biochem 59: 1958-1959
30. Harrison P and Cramer EM (1993) Platelet alpha-granules. Blood Rev 7: 52-62
31. Hauser S and Weich HA (1993) A heparin-binding form of placenta growth factor (P1GF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors 9: 259-268
32. Hawrylowicz CM, Santoro SA, Platt FM and Unanue ER (1989) Activated platelets express IL-1 activity. J Immunol 143: 4015-4018
33. Houck KA, Ferrara N, Winer J, Cachianes G, Li B and Leung DW (1991) The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5: 1806-1814
34. Houck KA, Leung DW, Rowland AM, Winer J and Ferrara N (1992) Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267: 26031-26037
35. Jiang X, Kanai H, Hiromura K, Sawamura M and Yano S (1995) Increased intraplatelet and urinary transforing growth factor-β in patients with multiple myeloma. Acta Haematol 94: 1-6
36. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N and Alitalo K (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VHGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. Embo J 15: 290-298
37. Kaloh O, Tauchi H, Kawaishi K, Kiniura A and Satow Y (1995) Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res 55: 5687-5692
38. Kendall RL and Thomas KA (1993) Inhibition of the vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 90: 10705-10709
39. Kluter H, Muller-Steinhardt M, Danzer S, Wilhelm D and Kirchner H (1995) Cytokines in platelet concentrates prepared from pooled buffy coats. Vox Sang 69: 38-43
40. Kondo S, Asano M, Matsuo K, Ohmori I and Suzuki H (1994) Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim Biophys Acta 1221: 211-214
41. Lyall F, Greer IA, Boswell F and Fleming R (1997) Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in preeclampsia. Br J Obstet Gynaecol 104: 223-228
42. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T and Sowa M (1996) Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77: 858-863
43. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P and Persico MG (1991) Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88: 9267-9271
44. Maglione D, Guerriero V, Viglietto G, Ferraro MG, Aprelikova O, Alitalo K, Del Vecchio S, Lei KJ, Chou JY and Persico MG (1993) Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PIGF), are transcribed from a single gene of chromosome 14. Oncogene 8: 925-931
45. Mattern J, Koomägi R and Volm M (1996) Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br J Cancer 73: 931-934
46. Matthews W, Jordan CT, Gavin M, Jenkins NA, Copeland NG and Lemischka IR (1991) A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci USA 88: 9026-9030
47. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W and Ullrich A (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72: 835-846
48. Muylle L and Peetermans ME (1994) Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates. Vox Sang 66: 14-17
49. Muylle L, Joos M, Wouters E, De Bock R and Peetermans ME (1993) Increased tumor necrosis factor α (TNFα), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNFα and IL-6 levels and febrile transfusion reactions. Transfusion 33: 195-199
50. O'Brien T, Cranston D, Fuggle S, Bicknell R and Harris AL (1995) Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res 55: 510-513
51. Oksanen K, Ebeling F, Kekomaki R, Elonen E, Sahlstedt L, Volin L, and Myllyla G (1994) Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat. Vox Sang 67: 356-361
52. Olofsson B, Pajusola K, Kaipainen A, Von Euler G, Joukov V, Saksela O, Orpana A, Petersson RF, Alitalo K and Eriksson U (1996) Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 93: 2576-2581
53. Paavonen K, Horelli-Kuitunen N, Chilov D, Kukk E, Pennanen S, Kallioniemi OP, Pajusola K, Olofsson B, Eriksson U, Joukov V, Palotie A and Alitalo K (1996) Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q 13 and 4q34, respectively. Circulation 93: 1079-1082
54. Saleh M, Stacker SA and Wilks AF (1996) Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res 56: 393-401
55. Sato K, Terada K, Takahashi S, Saito M, Moriyama M, Kakinuma H, Suzuki Y, Kato M and Kato T (1994) Frequent overexpression of vascular endothelial growth factor gene in human renal cell carcinoma. Tohoku J Ex Med 173: 355-360
56. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS and Dvorak HF (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985
57. Senger DR, Perruzzi CA, Feder J and Dvorak HF (1986) A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46: 5629-5632
58. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H and Sato M (1990) Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5: 519-524
59. Soker S, Svahn CM and Neufeld G (1993) Vascular endothelial growth factor is inactivated by binding to α2-macroglobulin and the binding is inhibited by heparin. J Biol Chem 268: 7685-7691
60. Stack G and Snyder EL (1994) Cytokine generation in stored platelet concentrates. Transfusion 34: 20-25
61. Takahashi A, Sasaki H, Kim SJ, Tobisu K, Kakizoe T, Tsukamoto T, Kumamoto Y, Sugimura T and Terada M (1994) Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res 54: 4233-4237
62. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR and Ellis LM (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55: 3964-3968
63. Takano S, Yoshii Y, Kondo S, Suzuki H, Maruno T, Shirai S, and Nose T (1996) Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 56: 2185-2190
64. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL and Shows TB (1991) Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6: 1677-1683
65. Thomas KA (1996) Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 271: 603-606
66. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC and Abraham JA (1991) The human gene for vascular enuothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954
67. Toi M, Kashitani J and Tominaga T (1993) Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 55: 371-374
68. Toi M, Hoshina S, Takayanagi T and Tominaga T (1994) Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. J J Cancer Res 85: 1045-1049
69. Warren RS, Yuan H, Matli MR, Gillett NA and Ferrara N (1995) Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 95: 1789-1797
70. Watanahe O, Arimura K, Kitajima I, Osame M and Maruyama I (1996) Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 347: 702